A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Cysteamine

DRUG

Zidovudine

Trial Locations (6)

33614

Infectious Disease Research Institute Inc, Tampa

75235

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

117948153

SUNY / Health Sciences Ctr at Stony Brook, Stony Brook

271571042

Bowman Gray School of Medicine / North Carolina Baptist Hosp, Winston-Salem

701122699

Tulane Univ Med School, New Orleans

02910

Independent Research Nurses Inc, Cranston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mylan Laboratories

INDUSTRY

NCT00002110 - A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease | Biotech Hunter | Biotech Hunter